Alterity Therapeutics (ATHE) Non-Current Assets (2009 - 2026)

Alterity Therapeutics has reported Non-Current Assets for 18 years, with the latest figure at $135175.1 in Q2 2026.

• On a quarterly basis, Non-Current Assets rose 36.02% year-over-year to $135175.1 in Q2 2026; TTM through Jun 2026 was $373203.6, a 21.64% increase from a year earlier, with the FY2026 full-year figure at $135175.1, up 36.02% from the prior year.
• Non-Current Assets was $135175.1 for Q2 2026 at Alterity Therapeutics, up from $62953.8 in the prior quarter.
• The five-year high for Non-Current Assets was $156520.4 in Q2 2022, with the low at $1868.8 in Q2 2024.
• Average Non-Current Assets over 5 years is $86542.8, with a median of $99378.6 recorded in 2025.
• The sharpest annual moves came in 2023 and 2025: Non-Current Assets tumbled 98.28% in 2023, then surged 5217.69% in 2025.
• Over 5 years, Non-Current Assets stood at $114742.3 in 2022, then advanced by 13.18% to $129861.5 in 2023, then slumped by 41.71% to $75696.1 in 2024, then dropped by 16.83% to $62953.8 in 2025, then jumped by 114.72% to $135175.1 in 2026.
• The last three Non-Current Assets figures came in at $135175.1 (Q2 2026), $62953.8 (Q4 2025), and $99378.6 (Q2 2025), per Business Quant data.